Pharma News

Investing in Stability: Q&A With James Saperstein, CEO of FourStory Bio Pharma

Saperstein discusses the current conditions that are impacting investors’ view of the life sciences industry.

Source link
#Investing #Stability #QampA #James #Saperstein #CEO #FourStory #Bio #Pharma

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *